CAC
MRK icon

Core Alternative Capital’s Merck MRK Stock Holding History

Core Alternative Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.27M Sell
43,783
-1,963
-4% -$227K 1.55% 21
2025
Q4 		$4.82M Buy
45,746
+1,633
+4% +$153K 1.33% 28
2025
Q3 		$3.7M Sell
44,113
-6,596
-13% -$543K 1.07% 43
2025
Q2 		$4.01M Sell
50,709
-8,254
-14% -$656K 1.1% 42
2025
Q1 		$5.29M Sell
58,963
-11,423
-16% -$1.07M 1.27% 31
2024
Q4 		$7M Sell
70,386
-3,061
-4% -$316K 1.46% 25
2024
Q3 		$8.34M Sell
73,447
-6,497
-8% -$772K 1.61% 20
2024
Q2 		$9.9M Sell
79,944
-10,101
-11% -$1.3M 1.98% 8
2024
Q1 		$11.9M Sell
90,045
-20,408
-18% -$2.52M 2.13% 7
2023
Q4 		$12M Sell
110,453
-25,866
-19% -$2.68M 2.06% 9
2023
Q3 		$14M Sell
136,319
-3,840
-3% -$414K 2.16% 11
2023
Q2 		$16.2M Sell
140,159
-28,947
-17% -$3.29M 2.37% 9
2023
Q1 		$18M Sell
169,106
-3,890
-2% -$420K 2.4% 9
2022
Q4 		$19.2M Buy
172,996
+19,048
+12% +$1.95M 2.44% 12
2022
Q3 		$13.3M Buy
153,948
+59,884
+64% +$5.35M 2.11% 23
2022
Q2 		$8.58M Buy
94,064
+16,574
+21% +$1.47M 2.03% 18
2022
Q1 		$6.36M Sell
77,490
-21,726
-22% -$1.71M 1.7% 36
2021
Q4 		$7.53M Buy
99,216
+2,721
+3% +$217K 1.51% 40
2021
Q3 		$7.25M Buy
96,495
+9,589
+11% +$729K 1.52% 41
2021
Q2 		$6.76M Buy
86,906
+11,648
+15% +$866K 1.57% 42
2021
Q1 		$5.54M Buy
75,258
+7,066
+10% +$521K 1.57% 41
2020
Q4 		$5.32M Buy
68,192
+6,935
+11% +$530K 1.59% 39
2020
Q3 		$4.85M Sell
61,257
-5,820
-9% -$456K 1.65% 37
2020
Q2 		$4.95M Buy
67,077
+1,343
+2% +$101K 1.55% 44
2020
Q1 		$4.83M Buy
65,734
+38,598
+142% +$3.03M 1.69% 30
2019
Q4 		$2.35M Buy
+27,136
New +$2.23M 2.16% 24

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Core Alternative Capital's MRK Position: Q1 2026 in Review

Core Alternative Capital reduced its Merck (MRK) stake by 4.3% in Q1 2026, selling an estimated $227K and leaving 43,783 shares worth $5.27M. The position accounts for 1.55% of the portfolio, ranked #21.

Core Alternative Capital first reported a position in MRK in Q4 2019 and has held it in 26 quarters since. The position peaked at $19.2M in Q4 2022. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Core Alternative Capital held 43,783 shares of Merck worth $5.27M as of Q1 2026.
  • Core Alternative Capital sold 1,963 Merck shares in Q1 2026, an estimated $227K.
  • Merck made up 1.55% of Core Alternative Capital's portfolio in Q1 2026, its #21 holding.
  • Core Alternative Capital first reported a position in Merck in Q4 2019 and has held it in 26 quarters since.
  • Core Alternative Capital's Merck position peaked at $19.2M in Q4 2022.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Core Alternative Capital's 13F filing for Q1 2026, filed 30 Apr 2026.